Specialised Therapeutics is thrilled to announce the official opening of its Thailand office, as we continue our mission to provide specialist therapies to patients across South East Asia. We are determined to ensure our medicines reach as many eligible patients as possible – particularly in oncology, with almost 200,000 Thai residents diagnosed with cancer every year (*Globocan 2020).
In a statement, our CEO Carlo Montagner said: “We look forward to working with the Thailand FDA as well as doctors throughout Thailand to introduce some of our portfolio therapies to this new and important region. Ultimately we are determined to make a difference for patients and to help ensure they are provided timely access to global therapies.”